KalVista Pharmaceuticals (KALV) Equity Ratio (2014 - 2025)
KalVista Pharmaceuticals recorded quarterly Equity Ratio of 0.19 in Q3 2025, down 50.24% quarter-over-quarter from 0.38 in Q2 2025, and down 78.07% year-over-year from 0.86 in Q3 2024.
KalVista Pharmaceuticals' Equity Ratio history runs 12 years deep, the most recent figure standing at 0.19 for Q3 2025.
- In Q3 2025, Equity Ratio fell 78.07% year-over-year to 0.19; the TTM figure through Jul 2025 stood at 0.19 (down 78.07% YoY), while the FY2025 annual figure was 0.38, down 56.65% from the prior year.
- Equity Ratio came in at 0.19 for Q3 2025 at KalVista Pharmaceuticals, down from 0.38 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.95 in Q2 2021 to a low of 0.19 in Q3 2025.
- A 5-year average of 0.8 and a median of 0.88 in 2023 frame the typical range for Equity Ratio.
- Across the five-year window, Equity Ratio advanced 8.33% in 2021 and tumbled 78.07% in 2025, its largest moves.
- KalVista Pharmaceuticals' Equity Ratio stood at 0.93 in 2021, then fell by 5.34% to 0.88 in 2022, then decreased by 6.6% to 0.82 in 2023, then tumbled by 32.41% to 0.56 in 2024, then sank by 66.05% to 0.19 in 2025.
- According to Business Quant data, Equity Ratio over the past three periods registered 0.19, 0.38, and 0.56 for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.21 |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | 0.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 0.19 |
| Apr 30, 2025 | 0.38 |
| Dec 31, 2024 | 0.56 |
| Oct 31, 2024 | 0.83 |
| Jul 31, 2024 | 0.86 |
| Apr 30, 2024 | 0.88 |
| Jan 31, 2024 | 0.78 |
| Oct 31, 2023 | 0.82 |
| Jul 31, 2023 | 0.87 |
| Apr 30, 2023 | 0.88 |
| Jan 31, 2023 | 0.91 |
| Oct 31, 2022 | 0.88 |
| Jul 31, 2022 | 0.90 |
| Apr 30, 2022 | 0.91 |
| Jan 31, 2022 | 0.92 |
| Oct 31, 2021 | 0.93 |
| Jul 31, 2021 | 0.94 |
| Apr 30, 2021 | 0.95 |
| Jan 31, 2021 | 0.88 |
| Oct 31, 2020 | 0.86 |
| Jul 31, 2020 | 0.89 |
| Apr 30, 2020 | 0.91 |
| Jan 31, 2020 | 0.87 |
| Oct 31, 2019 | 0.87 |
| Jul 31, 2019 | 0.85 |
| Apr 30, 2019 | 0.82 |
| Jan 31, 2019 | 0.82 |
| Oct 31, 2018 | 0.81 |
| Jul 31, 2018 | 0.46 |
| Apr 30, 2018 | 0.44 |
| Jan 31, 2018 | 0.43 |
| Oct 31, 2017 | 0.89 |
| Jul 31, 2017 | 0.87 |
| Apr 30, 2017 | 0.91 |
| Jan 31, 2017 | 0.92 |
| Mar 31, 2016 | 0.87 |
| Dec 31, 2015 | 0.87 |
| Sep 30, 2015 | 0.88 |
| Jun 30, 2015 | 0.88 |
| Mar 31, 2015 | -6.35 |
| Dec 31, 2014 | -6.65 |